Skip to main content

2 Result(s)

within Simon Doss-Gollin Remove this filter

and

  1. Article

    Open Access

    Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen

    Adjuvants can enhance vaccine immunogenicity, but their mechanism of action is often incompletely understood, hampering rapid applicability for pandemic vaccines. Herein, we characterized the cellular and mole...

    Simon Doss-Gollin, Sanya Thomas, Byron Brook, Kimia Abedi, Célia Lebas… in npj Vaccines (2023)

    Download PDF (3641 KB) View Article

  2. Article

    Open Access

    CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns

    Respiratory syncytial virus is a leading cause of morbidity and mortality in children, due in part to their distinct immune system, characterized by impaired induction of Th 1 immunity. Here we show applicatio...

    Simon D. van Haren, Gabriel K. Pedersen, Azad Kumar… in Nature Communications (2022)

    Download PDF (3654 KB) View Article